General Information of Drug (ID: DMMWIHC)

Drug Name
CYT 99007 Drug Info
Indication
Disease Entry ICD 11 Status REF
Acquired immune deficiency syndrome 1C62.3 Phase 2 [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
TTD Drug ID
DMMWIHC

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ADX-914 DMYM6FU Atopic dermatitis EA80 Phase 2 [3]
PF-06342674 DMASKX9 Type-1 diabetes 5A10 Phase 1 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin 7 receptor alpha (IL7R) TTAWI51 IL7RA_HUMAN Binder [2]

References

1 ClinicalTrials.gov (NCT01339000) Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy. U.S. National Institutes of Health.
2 Perspectives on interleukin-7 therapy in HIV infection. Curr Opin HIV AIDS. 2007 May;2(3):228-33.
3 Clinical pipeline report, company report or official report of Q32bio
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)